CFDE Data Portal | Search ITLN2

	Label	Description
	ITLN2 associations Collection (Entity type)	Associations for ITLN2_associations
	ITLN2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ITLN2 Gene (Entity type)	ENSG00000158764 - intelectin 2
	GSE147876,GSE147877 2 V 7 ENZALUTAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 5 V 0 MATRINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 11 V 6 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 4 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE145195 PPP2R3B overexpression 4 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

ITLN2 associations

Associations for ITLN2_associations

ITLN2 associations.tsv

A file from IDG as part of the Harmonizome project

ITLN2

ENSG00000158764 - intelectin 2

GSE147876,GSE147877 2 V 7 ENZALUTAMIDE HUMAN UP

A Gene Set from LINCS

GSE201309 5 V 0 MATRINE HUMAN UP

A Gene Set from LINCS

GSE216043 11 V 6 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 4 v 11 human up

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up

A Gene Set from LINCS

GSE145195 PPP2R3B overexpression 4 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.